An experimental drug currently being trialled for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers at the University of Cambridge has shown that the drug, favipiravir, is effective at reducing – and in some cases eliminating – norovirus infection in mice.
Researchers at the University of Cambridge, together with colleagues specialising in plastic surgery or histopathology in Austria, Australia, Liverpool and Swansea, have identified clues to explain how breast implants may, on very rare occasions, contribute to the development of lymphoma.
Miniature scaffolds made from collagen – the ‘glue’ that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair the heart after a heart attack.
New research reveals how bacteria construct tiny flagella ‘nanomachines’ outside the cell.
Scientists find mutant protein blocks HIV infection and transmission.
Approval concludes nearly 40-year epic journey from fundamental research to discovery of an effective treatment for active relapsing multiple sclerosis
Mutations might play a key role in the death of brain cells.
Research could lead to new drugs to turn ‘switch’ off.
Gavin Garland’s experiences of confronting cancer as a teenager influenced his choice of career as a molecular biologist working on the mechanisms of lymphoma. Now he’s running the Virgin London Marathon 2013 to raise funds for the charity that support the work of his lab.
Research paves way for the development of a vaccine for the contagious cancer which is driving Tasmanian devils to the brink of extinction.
© 2024 University of Cambridge